chr2-196841269-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_024989.4(PGAP1):c.2734C>T(p.Pro912Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000403 in 1,613,580 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_024989.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PGAP1 | NM_024989.4 | c.2734C>T | p.Pro912Ser | missense_variant | 27/27 | ENST00000354764.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PGAP1 | ENST00000354764.9 | c.2734C>T | p.Pro912Ser | missense_variant | 27/27 | 1 | NM_024989.4 | P1 | |
PGAP1 | ENST00000423035.5 | c.*2665C>T | 3_prime_UTR_variant, NMD_transcript_variant | 28/28 | 1 | ||||
PGAP1 | ENST00000422444.1 | c.445C>T | p.Pro149Ser | missense_variant | 4/4 | 2 | |||
PGAP1 | ENST00000459896.5 | n.105+1452C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000388 AC: 59AN: 152070Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000849 AC: 213AN: 250980Hom.: 0 AF XY: 0.000826 AC XY: 112AN XY: 135638
GnomAD4 exome AF: 0.000404 AC: 591AN: 1461510Hom.: 3 Cov.: 30 AF XY: 0.000396 AC XY: 288AN XY: 727048
GnomAD4 genome AF: 0.000388 AC: 59AN: 152070Hom.: 0 Cov.: 32 AF XY: 0.000350 AC XY: 26AN XY: 74286
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 17, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Hereditary spastic paraplegia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Nov 01, 2019 | - - |
Intellectual disability, autosomal recessive 42 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at